Literature DB >> 27604740

Advanced and High-Throughput Method for Mitochondrial Bioenergetics Evaluation in Neurotrauma.

Jignesh D Pandya1, Patrick G Sullivan2, Lai Yee Leung3, Frank C Tortella3, Deborah A Shear3, Ying Deng-Bryant3.   

Abstract

Mitochondrial dysfunction is one of the key posttraumatic neuropathological events observed in various experimental models of traumatic brain injury (TBI). The extent of mitochondrial dysfunction has been associated with the severity and time course of secondary injury following brain trauma. Critically, several mitochondrial targeting preclinical drugs used in experimental TBI models have shown improved mitochondrial bioenergetics, together with cortical tissue sparing and cognitive behavioral outcome. Mitochondria, being a central regulator of cellular metabolic pathways and energy producer of cells, are of a great interest for researchers aiming to adopt cutting-edge methodology for mitochondrial bioenergetics assessment. The traditional way of mitochondrial bioenergetics analysis utilizing a Clark-type oxygen electrode (aka. oxytherm) is time-consuming and labor-intensive. In the present chapter, we describe an advanced and high-throughput method for mitochondrial bioenergetics assessments utilizing the Seahorse Biosciences XF(e)24 Flux Analyzer. This allows for simultaneous measurement of multiple samples with higher efficiency than the oxytherm procedure. This chapter provides helpful guidelines for conducting mitochondrial isolation and studying mitochondrial bioenergetics in brain tissue homogenates following experimental TBI.

Entities:  

Keywords:  Brain metabolism; Mitochondria; Mitochondrial bioenergetics; Neurotrauma; Oxidative phosphorylation; Therapeutic drugs preclinical screening; Traumatic brain injury

Mesh:

Substances:

Year:  2016        PMID: 27604740     DOI: 10.1007/978-1-4939-3816-2_32

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Mitochondrial uncoupling prodrug improves tissue sparing, cognitive outcome, and mitochondrial bioenergetics after traumatic brain injury in male mice.

Authors:  W Brad Hubbard; Christopher L Harwood; John G Geisler; Hemendra J Vekaria; Patrick G Sullivan
Journal:  J Neurosci Res       Date:  2018-07-31       Impact factor: 4.164

2.  Bioenergetic restoration and neuroprotection after therapeutic targeting of mitoNEET: New mechanism of pioglitazone following traumatic brain injury.

Authors:  Heather M Yonutas; W Brad Hubbard; Jignesh D Pandya; Hemendra J Vekaria; Werner J Geldenhuys; Patrick G Sullivan
Journal:  Exp Neurol       Date:  2020-02-10       Impact factor: 5.330

3.  Combination Drug Therapy of Pioglitazone and D-cycloserine Attenuates Chronic Orofacial Neuropathic Pain and Anxiety by Improving Mitochondrial Function Following Trigeminal Nerve Injury.

Authors:  Danielle N Lyons; Liping Zhang; Jignesh D Pandya; Robert J Danaher; Fei Ma; Craig S Miller; Patrick G Sullivan; Cristian Sirbu; Karin N Westlund
Journal:  Clin J Pain       Date:  2018-02       Impact factor: 3.442

Review 4.  Targeting mitochondrial dysfunction in CNS injury using Methylene Blue; still a magic bullet?

Authors:  Hemendra J Vekaria; Lora Talley Watts; Ai-Ling Lin; Patrick G Sullivan
Journal:  Neurochem Int       Date:  2017-04-07       Impact factor: 3.921

5.  Age- and Organ-Specific Differences in Mitochondrial Bioenergetics in Brown Norway Rats.

Authors:  Jignesh D Pandya; Matthew Valdez; Joyce E Royland; Robert C MacPhail; Patrick G Sullivan; Prasada Rao S Kodavanti
Journal:  J Aging Res       Date:  2020-04-01

6.  A method for assessing tissue respiration in anatomically defined brain regions.

Authors:  Erica Underwood; John B Redell; Jing Zhao; Anthony N Moore; Pramod K Dash
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

7.  Temporal changes in inflammatory mitochondria-enriched microRNAs following traumatic brain injury and effects of miR-146a nanoparticle delivery.

Authors:  Wang-Xia Wang; Paresh Prajapati; Hemendra J Vekaria; Malinda Spry; Amber L Cloud; Patrick G Sullivan; Joe E Springer
Journal:  Neural Regen Res       Date:  2021-03       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.